“The next step will be to determine why it isn’t effective for certain patients and figure out a way to make it work for them. Right now therapies use a patient’s own immune system to recognize a tumor, but they can’t yet be customized for each unique immune system or cancer,” he said.
Currently, at least seven drug companies are testing some form of immunotherapy for treating cancer. Atkins said he expected several drugs to be approved for wider use by the end of this year and several more by the end of next year.
The Benefits of Personalized Cancer Medicines Tweet Chat Today at 1 p.m., ET Join the ABC News Health tweet chat today at 1 p.m., ET to learn more about how individually targeted medicines and therapies are revolutionizing cancer treatment. We have scientists from around the country will be gathered in one place and tweeting in from the American Association for Cancer Research annual meeting in San Diego. This is a real opportunity to learn where the world’s top experts believe personalized medicine to treat cancer is heading.
As always, ABC News chief health and medical correspondent will moderate this discussion. You can join the conversation too. Here’s how.